Product Information
TRIENTINE HCL 250 MG CAPSULE is a generic product labeled by Novadoz Pharmaceuticals LLC, priced at $2.3025 per EA under NDC 72205000891. Its NADAC has been published 62 times since Jun 18, 2025.
FDA first approved this application on May 22, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Novadoz Pharmaceuticals LLCNDC
72205000891
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
7/22/2026
Active Ingredients
TRIENTINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211134FDA Approved
5/22/2019
TE Code
AB
On Market Since
5/22/2019
Pharmacological Classes
Price Statistics
The NADAC for TRIENTINE HCL 250 MG CAPSULE has been published 62 times since Jun 18, 2025, and over the history we have for it it has declined 48.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.3025 per EA |
|---|---|
| All-time high | $4.4843 (Jul 16, 2025) |
| All-time low | $2.3025 (Jun 17, 2026) |
| 52-week high | $4.3782 |
| 52-week low | $2.3025 |
| Median price | $4.3033 |
| Average price | $3.7280 |
| Largest weekly change | -21.6% (Mar 18, 2026) |
| Weeks tracked | 62 |
| Tracking since | Jun 18, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Trientine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TRIENTINE HCL 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TRIENTINE HCL 250 MG CAPSULE, manufactured by Novadoz Pharmaceuticals LLC, is $2.3025 per EA (NDC 72205000891), effective Aug 19, 2026.
How has the price of TRIENTINE HCL 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TRIENTINE HCL 250 MG CAPSULE has declined 48.7%. It has been tracked across 62 weekly CMS publications since Jun 18, 2025.
What are the highest and lowest recorded NADAC prices for TRIENTINE HCL 250 MG CAPSULE?
Since Jun 18, 2025, the NADAC for TRIENTINE HCL 250 MG CAPSULE has ranged from a low of $2.3025 (Jun 17, 2026) to a high of $4.4843 (Jul 16, 2025), with a median of $4.3033 per EA.
Are there cheaper alternatives to TRIENTINE HCL 250 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of TRIENTINE HCL 250 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TRIENTINE HCL 250 MG CAPSULE?
TRIENTINE HCL 250 MG CAPSULE (NDC 72205000891) is labeled by Novadoz Pharmaceuticals LLC, and CMS classifies it as a generic product.